Work

Poster: ABCL-073 Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results From the Phase III POLARIX Study

Year: 2022
Type: article
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4296969016
FWCI:
Cites:
Cited by:
Related to: 10